Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$39.53 +0.26 (+0.65%)
As of 04:00 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$39.05
$39.64
50-Day Range
$35.90
$43.38
52-Week Range
$31.30
$44.31
Volume
548,901 shs
Average Volume
2.86 million shs
Market Capitalization
$252.09 billion
P/E Ratio
N/A
Dividend Yield
2.20%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Only a handful of people know the setup that's defied these chaotic markets.
Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day. That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan. Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout. Naturally, no one can guarantee what the market does in the future… But these simple daily options setups have paid out with the market rallying, dropping, or staying flat. And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself…
Tandem Diabetes, Roche enter patent settlement agreement
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the start of the year. Since then, RHHBY stock has increased by 13.3% and is now trading at $39.5250.
View the best growth stocks for 2025 here
.

The following companies are subsidiaries of Roche: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more.

Top institutional shareholders of Roche include GAMMA Investing LLC (0.01%), Boston Common Asset Management LLC (0.01%), OLD National Bancorp IN and Altrius Capital Management Inc.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/29/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
13.98
P/E Growth
2.18
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$3.06 per share
Price / Cash Flow
12.82
Book Value
$5.81 per share
Price / Book
6.76

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$250.46 billion
Optionable
Not Optionable
Beta
0.46

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners